14 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 14 of 14 clinical reviews.
A physician-reviewed guide to how low-dose naltrexone affects sleep, concentration, physical activity, and school performance in adolescents aged 12 to 17, with dosing context, timing strategies, and monitoring guidance.
A detailed caregiver guide to administering compounded low-dose naltrexone (LDN) to adolescents aged 12 to 17, including dosing protocols, timing, storage, side-effect monitoring, and when to contact the prescribing clinician.
A comprehensive clinical guide covering low-dose naltrexone (LDN) use in adolescents ages 12 to 17 and the steps needed for a safe, effective transition to adult care, including dosing, monitoring, and provider handoff protocols.
A clinician-reviewed guide to off-label low-dose naltrexone (LDN) use in adults aged 65 and older, covering dosing, drug interactions, evidence from named trials, and practical prescribing considerations for geriatric patients.
A clinical guide to low-dose naltrexone (LDN) use in geriatric patients, covering cognitive effects, physical activity, driving safety, fatigue management, and daily-life considerations for adults aged 65 and older.
Board-reviewed caregiver guide to compounded low-dose naltrexone (LDN) in children under 12, covering dosing, timing, formulation, monitoring, and safety signals, with primary-source citations throughout.
A comprehensive clinical guide for caregivers managing low-dose naltrexone (LDN) in adults aged 65 and older, covering dosing, timing, storage, side-effect monitoring, and when to call the prescriber.
A clinical guide to low-dose naltrexone (LDN) use in adults 65 and older, covering dose adjustments, drug interactions, renal and hepatic considerations, and how to manage the transition from adult to geriatric care protocols.
A clinical review of low-dose naltrexone (LDN) use in adolescents aged 12 to 17, covering developmental safety, immune and neurological effects, dosing considerations, and what the current evidence actually shows.
A comprehensive clinical review of off-label low-dose naltrexone (LDN) use in adolescents aged 12 to 17, covering mechanism, dosing, evidence base, safety, and prescribing considerations.
A clinical review of low-dose naltrexone (LDN) for geriatric patients, covering immune modulation, neuroinflammation, dosing, safety, and the specific physiological changes that affect how adults 65+ respond to this compounded therapy.
A clinician-reviewed guide for parents and pediatric providers on how low-dose naltrexone affects school performance, physical activity, sleep, and daily routines in children under age 12.
A comprehensive clinical review of low-dose naltrexone (LDN) use in pediatric patients under age 12, covering neurodevelopmental effects, immune modulation, dosing considerations, and the current state of evidence.
A clinician-reviewed guide to managing low-dose naltrexone (LDN) in pediatric patients under 12, including dosing considerations, monitoring protocols, and a structured framework for transitioning to adult care providers.